Skip to main content
. Author manuscript; available in PMC: 2021 Nov 10.
Published in final edited form as: J Rheumatol. 2018 Jul 1;45(8):1153–1158. doi: 10.3899/jrheum.170518

Table 2.

Immunosuppressive agents at the baseline visit. Values are n (%).

Medication n = 82

No immunosuppression 45 (54.9)
Prednisone > 5 mg 20 (24.4)
Methotrexate 10 (12.2)
Mycophenolate mofetil 9 (11)
Cyclophosphamide 3 (3.7)
Azathioprine 2 (2.4)
Other 4 (4.9)